Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Congressional Budget Office Releases: Alternative Approaches to Reducing…
As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived…
Understanding the High Costs of Cancer Care: Insights from “Oncology…
Cancer care costs continue to rise, posing significant challenges for both patients and healthcare systems. In the latest episode…
Rare Disease Community Pushes Back Against Inflation Reduction Act
Bloomberg recently wrote about a push by the rare disease community for changes in the Inflation Reduction Act’s drug…
The 340B Program is Growing, But is it Benefitting Patients?
The Berkeley Research Group recently published an updated report that compared sales across federal prescription drug programs, to…
Brookings Institution Finds No Surprises Act Arbitration Results in Larger…
The Brookings Institution recently published a study on the outcomes under the No Surprises Act arbitration process, finding that…
Colorado Working to Be Second State to Import Drugs from Canada
Colorado’s General Assembly passed a law in 2019 that allowed the Colorado Department of Health Care Policy and Financing (HCPF)…
ICER Publishes Annual Unsupported Price Increase Report
Recently, the Institute for Clinical and Economic Review (ICER) published its annual Unsupported Price Increase Report,…
Could Low Prices Be the Cause of Generic Drug Shortages?
Generic drug shortages have been in the news for several months now, with many stakeholders and interested parties trying to find…
Biden Administration Outlines Plan to Effectively Remove Patent Rights from…
The Biden Administration recently published a draft proposal to exercise “march-in” rights regarding generic options for patented…
Policy and Medicine Compliance Update – November 2023 Issue Features…
Welcome to the latest edition of Policy and Medicine Compliance Update. In this month's coverage, we delve into the intricate…